Brain fog breakthrough? simple supplement boosts memory in long COVID
NCT ID NCT07184398
First seen Jun 26, 2026 ยท Last updated Jun 26, 2026
Summary
This study tested whether a daily whey protein supplement called Immunocal could help with memory and attention problems after COVID-19. 120 adults with mild to moderate cognitive issues were split into three groups: Immunocal, cognitive rehab workshops, or no treatment. After 12 weeks, both the supplement and rehab groups showed significant improvements in attention and memory compared to the control group. The supplement also improved physical endurance.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Immunocal (cysteine-rich whey protein isolate)
- What this could lead to
- If confirmed, this could offer a simple, non-drug option to help with brain fog and fatigue after COVID-19.
- What could go wrong
- This is a small, completed trial without long-term follow-up. The supplement is not a cure and may not work for everyone. More research is needed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 SARS-COV-2 INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Doctor's office
Cali, Valle del Cauca Department, 760001, Colombia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Donor t cells aim to fight severe COVID-19
- Personalized immune cell therapy aims to clear stubborn COVID-19 infections
- New ibuzatrelvir tablet put to the test in healthy volunteers
- Brain training shows promise for TBI recovery
- Massive data dive to measure Real-World power of updated COVID shots
- New pill aims to keep High-Risk COVID patients out of the hospital